MRK vs MU: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Micron Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-20.
Merck & Co., Inc. · Healthcare
$114.27
+3.3% upside to fair value
Grade C
High Quality
VS
Micron Technology, Inc. · Technology
$455.07
-45.0% upside to fair value
Grade D
High Quality
QuantHub Verdict
MRK has more upside to fair value
(+3.3%).
MU trades at a lower forward P/E
(21.2x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
MU |
| Current Price |
$114.27 |
$455.07 |
| Fair Value Estimate |
$118.00 |
$250.29 |
| Upside to Fair Value |
+3.3%
|
-45.0%
|
| Market Cap |
$282.2B |
$513.2B |
| Forward P/E |
22.4x
|
21.2x
|
| EV / EBITDA |
13.5x
|
13.8x
|
| Price / Sales |
4.3x
|
8.8x
|
| Price / FCF |
20.2x
|
49.9x
|
| Revenue Growth YoY |
+5.0%
|
+196.3%
|
| Gross Margin |
81.9%
|
58.4%
|
| Operating Margin |
27.5%
|
48.5%
|
| Return on Equity |
5.6%
|
40.8%
|
| Dividend Yield |
2.91% |
0% |
| FCF Yield |
4.95%
|
2.0%
|
| Analyst Consensus |
Overweight
|
Strong Buy
|
Investment Thesis
Merck delivered a clean Q1 2026 operational beat on April 30, with revenue of 16.3 billion dollars growing 5 percent year over year and Keytruda sales rising 12 percent to 8.0 billion dollars. The reported loss of 1.28 dollars per share, though better than the negative 1.47 dollar consensus estimate, reflected a 3.62 dollar per share IPR and D charge tied to the Cidara Therapeutics acquisition an…
Micron Technology, Inc. is a leading semiconductor company specializing in memory and storage solutions, with a dominant position in DRAM and NAND markets. The company benefits from a strong business quality characterized by high profitability, exceptional revenue growth of 196.3% year-over-year in the most recent quarter, and a robust return on equity of 40.8%. Despite these strengths, the stock…
Accumulation Zones
| Metric |
MRK |
MU |
| Zone Low |
$88.50 |
$187.72 |
| Zone High |
$100.30 |
$212.75 |
| In Buy Zone? |
No
|
No
|